Confronting Inequities in STI Prevention, Diagnostics and Care
Addressing STIs towards the elimination of new paediatric HIV and Hepatitis B and Congenital Syphilis (EMTCT)
Tuesday September 6th 2022, 16:30 – 18:00
Venue: Kalundu Conference Room
Moderator(s): Magdalena Barr-DiChiara, World Health Organization and Morkor Newman Owiredu, World Health Organization
Background: The global community has committed to the elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and hepatitis B virus (HBV). This commitment, in line with Global Health Sector Strategies for HIV, Sexually Transmitted Infections and Viral Hepatitis is to ensure the availability of quality reproductive and maternal and child health (MCH) services to reduce and control the transmission of HIV, syphilis and HBV between mothers and their children and to provide the best available prevention and treatment to the mother, such that incidence is reduced to a very low level and ceases to be a public health concern.
Session Goal: To advocate for and strengthen capacity of national programmes to plan and monitor responses towards Triple Elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus.
Session Objectives: In this session, we will present the Triple Elimination Initiative and describe the criteria for validation of elimination through sharing country experiences in achieving and assessing the foundational requirements for validation. The session will also describe how clinicians and clinical managers can make an impact towards eliminating new paediatric HIV and hepatitis B infections and congenital syphilis.
|16:30-16:35||Welcome and presentation of session objectives||Meg Doherty (WHO, Switzerland)|
|16:35-17:00||The Multi-disease elimination agenda: Triple Elimination of MTCT of HIV, syphilis and HBV and cervical cancer elimination (CCEI) Initiative||Morkor Newman Owiredu (WHO, Switzerland)|
|17:00-17:15||What can countries do to make Triple Elimination work? Experiences in validation and the Path to Elimination||Angela Mushavi (MOHCC, Zimbabwe)|
|17:15-17:55||Panel discussion: What can clinicians and clinical managers do to make Triple Elimination work?||Yamuna Mundade (WHO, Switzerland)
Kem Kusi (MOH, Botswana)
Nancy Kidula (WHO, Republic of Congo)
Funmi Lesi (WHO, Switzerland)
Magdalena Barr-DiChiara (WHO, Switzerland)
Boniface Dongmo Nguimfack (WHO, Switzerland)
|17:55-18:0||Closing||Morkor Newman Owiredu (WHO, Switzerland)|